Costs and outcomes associated with clopidogrel discontinuation in Medicare beneficiaries with acute coronary syndrome in the coverage gap

References

• RogerVLGoASLloyd-JonesDMHeart disease and stroke statistics – 2011 update: a report from the American Heart AssociationCirculation20111234e18e20921160056
   PubMed Web of Science ®Google Scholar
• KolanskyDMAcute coronary syndromes: morbidity, mortality, and pharmacoeconomic burdenAm J Manag Care200915Suppl 2S36S4119355807
   PubMedGoogle Scholar
• MenzinJWygantGHauchOJackelKFriedmanMOne-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims databaseCurr Med Res Opin200824246146818194592
   PubMed Web of Science ®Google Scholar
• AndersonJLAdamsCDAntmanEM2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelinesCirculation201112318e426e57921444888
   PubMed Web of Science ®Google Scholar
• AndersonJLAdamsCDAntmanEMACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to revise the 2002 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency MedicineCirculation20071167e148e30417679616
   PubMed Web of Science ®Google Scholar
• AntmanEMHandMArmstrongPW2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association task force on practice guidelinesJ Am Coll Cardiol200851221024718191746
   PubMed Web of Science ®Google Scholar
• KushnerFGHandMSmithSCJr2009 focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction (updating the 2004 guideline and 2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary intervention (updating the 2005 guideline and 2007 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice GuidelinesJ Am Coll Cardiol200954232205224119942100
   PubMed Web of Science ®Google Scholar
• LevineGNBatesERBlankenshipJC2011 ACCF/AHA/scai guideline for percutaneous coronary intervention. A report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines and the Society for Cardiovascular Angiography and InterventionsJ Am Coll Cardiol20115824e44e12222070834
   PubMed Web of Science ®Google Scholar
• BoggonRvan StaaTPTimmisAClopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction – a hospital registry-primary care linked cohort (MINAP-GPRD)Eur Heart J201132192376238621875855
   PubMed Web of Science ®Google Scholar
• ErnstFRJohnstonSCurkendallSEffect of early clopidogrel discontinuation on rehospitalization in acute coronary syndrome: results from two distinct patient populationsAm J Health Syst Pharm201168111015102421593230
   PubMed Web of Science ®Google Scholar
• GagliaMAJrWaksmanRSystematic review of thienopyridine discontinuation and its impact upon clinical outcomesEur Heart J201132192358236421804110
   PubMed Web of Science ®Google Scholar
• HoPMPetersonEDWangLIncidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndromeJAMA2008299553253918252883
   PubMed Web of Science ®Google Scholar
• HoPMTsaiTTWangTYAdverse events after stopping clopidogrel in post-acute coronary syndrome patients: insights from a large integrated healthcare delivery systemCirc Cardiovasc Qual Outcomes20103330330820354221
   PubMed Web of Science ®Google Scholar
• SpertusJAKettelkampRVanceCPrevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registryCirculation2006113242803280916769908
   PubMed Web of Science ®Google Scholar
• WiederkehrDBerensonKCascianoRClinical impact of early clopidogrel discontinuation following acute myocardial infarction hospitalization or stent implantation: analysis in a single integrated health networkCurr Med Res Opin20092592317232519635042
   PubMed Web of Science ®Google Scholar
• GrinesCLBonowROCaseyDEJrPrevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons, and American Dental Association, with representation from the American College of PhysiciansJ Am Coll Cardiol200749673473917291948
   PubMed Web of Science ®Google Scholar
• PallaresMJPowersERZwernerPLBarriers to clopidogrel adherence following placement of drug-eluting stentsAnn Pharmacother200943225926719193589
   PubMed Web of Science ®Google Scholar
• The Henry K. Kaiser Family FoundationMedicare Part D 2011: the coverage gap Available at: http://www.kff.org/medicare/upload/8222.pdfAccessed June 5, 2012
   Google Scholar
• PolinskiJMShrankWHHuskampHAChanges in drug utilization during a gap in insurance coverage: an examination of the Medicare Part D coverage gapPLoS Med201188e100107521857811
   PubMed Web of Science ®Google Scholar
• The RAND CorporationA look inside the “doughnut hole”How drug-benefit limits affect retiree prescription use Available at: http://www.rand.org/content/dam/rand/pubs/research_briefs/2007/RAND_RB9285.pdfAccessed June 5, 2012
   Google Scholar
• GuQZengFPatelBVTripoliLCPart D coverage gap and adherence to diabetes medicationsAm J Manag Care2010161291191821348561
   PubMed Web of Science ®Google Scholar
• ZhangYDonohueJMLaveJRThe effect of Medicare Part D on drug and medical spendingN Engl J Med20093611526119571283
   PubMed Web of Science ®Google Scholar
• ZhangYDonohueJMNewhouseJPLaveJRThe effects of the coverage gap on drug spending: a closer look at Medicare Part DHealth Aff (Millwood)2009282w317w32519189991
   PubMed Web of Science ®Google Scholar
• HalesJWGeorgeSHow the doughnut hole affects prescription fulfillment decisions involving cardiovascular medications for Medicare Part D enrolleesManag Care20101912364421291131
   PubMedGoogle Scholar
• PolinskiJMShrankWHGlynnRJAdverse health outcomes associated with the Medicare Part D coverage gapAbstract presented at the 27th International Society for PharmacoepidemiologyAugust 13–17, 2011Chicago, IL
   Google Scholar
• The Henry K Kaiser Family FoundationThe Medicare Part D coverage gap: costs and consequences in 2007 Available at: http://www.kff.org/medicare/upload/7811.pdfAccessed June 5, 2012
   Google Scholar
• The Healthcare Costs and Utilization ProjectChronic condition indicator (CCI) for ICD-9-CM Available at: http://www.hcup-us.ahrq.gov/toolssoftware/chronic/chronic.jspAccessed June 5, 2012
   Google Scholar
• NairKVFrech-TamasFJanSComparing pre-gap and gap behaviors for Medicare beneficiaries in a Medicare managed care planJ Health Care Finance2011382385322372031
   PubMedGoogle Scholar
• NeumanPCubanskiJMedicare Part D update – lessons learned and unfinished businessN Engl J Med2009361440641419625722
   PubMed Web of Science ®Google Scholar